Article Text

A7.4 The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis
  1. J Shi,
  2. HW van Steenbergen,
  3. JAB van Nies,
  4. AHM van der Helm-van Mil,
  5. TWJ Huizinga,
  6. REM Toes,
  7. LA Trouw
  1. Department of Rheumatology, LUMC, Leiden, The Netherlands


Background and objectives Anti-carbamylated protein (anti-CarP) antibodies have been described in rheumatoid arthritis (RA) and arthralgia. In anti-CCP2 negative RA patients the presence of anti-CarP was associated with more severe joint destruction. Here we investigated the sensitivity and specificity of anti-CarP antibodies for RA in a setting of early arthritis.

Materials and methods Anti-carbamylated fetal calf serum (anti-Ca-FCS), anti-CCP2 antibodies and rheumatoid factor (RF) IgM were measured by ELISA using serum samples available from the Leiden Early Arthritis Clinic cohort (EAC). For the anti-CarP antibodies we used as a cut-off for positivity the mean + 2 times the standard deviation of healthy controls.

Results In total 2086 sera of Leiden EAC patients suffering from early arthritis were analysed for the presence of anti-Ca-FCS antibodies. Anti-CarP antibodies were present in 26% of the patients and in 2% of the controls. We observed that the sensitivity and specificity of anti-Ca-FCS in the EAC cohort for RA are 44% and 89%. As a reference the sensitivity and specificity of anti-CCP2 antibodies are 54% and 96% and for RF IgM are 59% and 91%. Analysing the early arthritis patients that did not fulfil the EULAR/ACR 2010 criteria for RA that were anti-CarP positive (n = 127) revealed that these patients were mainly diagnosed as undifferentiated arthritis (45%), reactive arthritis (9%), psoriatic arthritis (9%) or peripheral spondyloarthritis (8%).

Conclusions Anti-CarP antibodies are predominantly present in RA but can also be detected in other forms of arthritis. The prognostic relevance of anti-CarP antibodies in these latter patients will have to be determined.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.